Paul T Quinlan
CIK 1333277 · General Counsel · last filed 2026-03-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.22M
Companies
3
Total Filings
66
Lifetime Open-Market Net
-$1.59M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ORKA | General Counsel | 31,767 | $69.89 | $2.22M | -$30.3K | 3 | 2026-03-17 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | General Counsel | 0 | $32.48 | $0 | -$1.50M | 18 | 2024-03-22 |
| TerraVia Holdings, Inc. (TVIA) Delisted | General Counsel | 218,403 | — | — | -$58.2K | 5 | 2017-03-13 |
Recent Filings · Page 4 of 7
66 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-03-05 | — | Grant (A) | — | $0 | |
| 2015-03-04 | — | Mixed | +19,253 | -$15.3K | |
| 2015-02-23 | — | Grant (A) | — | $0 | |
| 2015-02-20 | — | Mixed | — | $0 | |
| 2014-12-22 | — | Grant (A) | — | $0 | |
| 2014-09-11 | — | Sell (S) | −16,562 | -$141.2K | |
| 2014-08-19 | — | Mixed | −2,500 | -$66.0K | |
| 2014-07-22 | — | Mixed | — | -$44.7K | |
| 2014-03-19 | — | Mixed | — | -$72.3K | |
| 2014-03-04 | — | Sell (S) | −3,125 | -$38.1K |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.